Brief: Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test To Aid Physician Diagnosis Of Alzheimer's Disease
24/10/2023 22:12
Oct 24 (Reuters) - Quanterix Corp QTRX.O :
* QUANTERIX LAUNCHES HIGH ACCURACY P-TAU 217 BLOOD BIOMARKER
TEST
TO AID PHYSICIAN DIAGNOSIS OF ALZHEIMER’S DISEASE
Source text for Eikon: ID:nBw6G9JvJa
Further company coverage: QTRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Quanterix
See all newsBrief: Alzpath And Quanterix Expand Strategic Licensing Agreement To Advance Next Generation Alzheimer's Disease Biomarker Research
Quanterix Corporation reports results for the quarter ended June 30 - Earnings Summary
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Quanterix Corporation expected to post a loss of 46 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 46 cents a share - Earnings Preview